Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study.
Paul K KeithJuthaporn CowanAmin KananiHarold KimGina LacuestaJason K LeeJie ChenMichelle ParkAndré GladiatorPublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2023)
Keyphrases